Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Non Operating Income (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Non Operating Income for 2 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 49.81% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2025, down 201.04% year-over-year, with the annual reading at $523000.0 for FY2025, 79.84% down from the prior year.
  • Non Operating Income hit -$1.8 million in Q4 2025 for Connect Biopharma Holdings, down from -$7000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.7 million in Q1 2024 to a low of -$3.6 million in Q4 2024.